Sachin Kumar Singh

Prof. Sachin Kumar Singh

Lovely Professional University, Phagwāra, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2021 in Microfluidics and Nanofluidics
Verified
Journal Article
Closed access
PDF file
PPPrapti Pattanayak
Prapti Pattanayak
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH
MGMonica Gulati
Monica Gulati
SVSukriti Vishwas
Sukriti Vishwas
BKBhupinder Kapoor
Bhupinder Kapoor
VKVijay Kumar
Vijay Kumar

18 April 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RKRubiya Khursheed
Rubiya Khursheed
KDKamal Dua
Kamal Dua
SVSukriti Vishwas
Sukriti Vishwas
MGMonica Gulati
Monica Gulati
NJNiraj Kumar Jha
Niraj Kumar Jha
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH
The current advancements in nanotechnology are as an outcome of the development of engineered nanoparticles. Various metallic nanoparticles have been extensively explored for various biomedical applications. They attract lot of attention in biomedical field due to their significant inert nature, and nanoscale structures, with size similar to many biological molecules. Their intrinsic characteristics which include electronic, optical, physicochemical and, surface plasmon resonance, that can be changed by altering certain particle characteristics such as size, shape, environment, aspect ratio, ease of synthesis and functionalization properties have led to numerous applications in various fields of biomedicine. These include targeted drug delivery, sensing, photothermal and photodynamic therapy, imaging, as well as the modulation of two or three applications. The current article also discusses about the various properties of metallic nanoparticles and their applications in cancer imaging and therapeutics. The associated bottlenecks related to their clinical translation are also discussed.

1 August 2021 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
KAKhalid Saad Alharbi
Khalid Saad Alharbi
NFNeeraj Kumar Fuloria
Neeraj Kumar Fuloria
SFShivkanya Fuloria
Shivkanya Fuloria
SRSk Batin Rahman
Sk Batin Rahman
WAWaleed Hassan Al-Malki
Waleed Hassan Al-Malki
GGGaurav Gupta
Gaurav Gupta

1 November 2019 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RKRubiya Khursheed
Rubiya Khursheed
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH
SWSheetu Wadhwa
Sheetu Wadhwa
BKBhupinder Kapoor
Bhupinder Kapoor
MGMonica Gulati
Monica Gulati
Kamal DuaKamal Dua
Kamal Dua

21 February 2022 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
JKJaskiran Kaur
Jaskiran Kaur
MGMonica Gulati
Monica Gulati
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH
GKGowthamarajan Kuppusamy
Gowthamarajan Kuppusamy
BKBhupinder Kapoor
Bhupinder Kapoor
LCLeander Corrie
Leander Corrie

29 December 2022 in ACS Omega
Verified
Journal Article
Open access
ASAkshansh Sharma
Akshansh Sharma
DSDevanshi Shambhwani
Devanshi Shambhwani
SPSadanand Pandey
Sadanand Pandey
Jay SinghJay Singh
Jay Singh
HLHauzel Lalhlenmawia
Hauzel Lalhlenmawia
Deepak KumarDeepak Kumar
Deepak Kumar
Carcinoma of the lungs is among the most menacing forms of malignancy and has a poor prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of conventional therapy. Therefore, drug delivery strategies that may overcome undesired damage to healthy cells, boost therapeutic efficacy, and act as imaging tools are currently gaining much attention. Advances in material science have resulted in unique nanoscale-based theranostic agents, which provide renewed hope for patients suffering from lung cancer. Nanotechnology has vastly modified and upgraded the existing techniques, focusing primarily on increasing bioavailability and stability of anti-cancer drugs. Nanocarrier-based imaging systems as theranostic tools in the treatment of lung carcinoma have proven to possess considerable benefits, such as early detection and targeted therapeutic delivery for effectively treating lung cancer. Several variants of nano-drug delivery agents have been successfully studied for therapeutic applications, such as liposomes, dendrimers, polymeric nanoparticles, nanoemulsions, carbon nanotubes, gold nanoparticles, magnetic nanoparticles, solid lipid nanoparticles, hydrogels, and micelles. In this Review, we present a comprehensive outline on the various types of overexpressed receptors in lung cancer, as well as the various targeting approaches of nanoparticles.